Ramucirumab - CISMeF

Preferred Label : Ramucirumab;

MeSH definition : A humanized monoclonal antibody and antagonist of VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2).;

MeSH hyponym : IMC1121B; IMC-1121B; 1121B;

UNII : D99YVK4L0X;

Details

Origin ID

D000096662;

UMLS CUI

C2742502;

ATC code(s)
- ramucirumab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- angiogenesis inhibitors [MeSH Descriptor]
Record concept(s)
- Cyramza [MeSH concept]
- IMC 1121B [MeSH concept]
- LY3009806 [MeSH concept]
- Ramucirumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing ramucirumab (medicinal product) [SNOMED CT concept]
- Ramucirumab [Substance BNPC]
- Ramucirumab [NCIt concept]
- Ramucirumab (substance) [SNOMED CT concept]
- ramucirumab [ATC Code]
Validated automatic mappings to BTNT
- ramucirumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients